Understanding the mechanisms of functionally selective antipsychotic drugs: Implications for new generation antipsychotic drugs

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1008473

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Schizophrenia is a chronic and devastating disease that ranks among the top 10 disabilities in developed countries. It places a significant burden on the Australian health system, costing about $1.5 billion each year. This project aims to reveal the mechanisms of new functionally selective antipsychotic drugs, which achieve an excellent therapeutic efficacy with low side-effects. Understanding these mechanisms will provide novel directions for the design of new generation antipsychotic drugs.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $371,745.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Psychology and Cognitive Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antipsychotic | antipsychotic drugs | dopamine | psychopharmacology | schizophrenia | side-effects | therapeutic effects | therapeutics

Related Links